Funding for this research was provided by:
research to prevent blindness
Received: 18 June 2021
Accepted: 3 November 2021
First Online: 18 November 2021
: This retrospective chart review study adhered to the 1964 Declaration of Helsinki and its later amendments and was Health Insurance Portability and Accountability Act (HIPAA) compliant. Approval was obtained from the Institutional Review Board (IRB) at the Johns Hopkins University School of Medicine.
: Not applicable.
: JFA is a consultant for Allergan Inc, Bayer Healthcare Pharmaceuticals, DORC International, bv/Dutch Ophthalmic, receives royalties from Springer SBM LLC, receives research grant support from Topcon Medical Systems Inc. (not conflicting with this manuscript). JTH received grant funding from Bayer Healthcare Pharmaceuticals and Clover Therapeutics for unrelated projects. SSO participated on an advisory board for Alimera Sciences Inc.